Recent technological advancements have made recovery from paralysis a real possibility for the first time in history.

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...

The study suggests that targeted brain stimulation could help bridge this gap. Academic learning has profound implications ...

Traditional and new laboratory tools along with advances in AI are outlining a new paradigm in human disease modeling.

Experimental myosin inhibitor MT-125 sensitizes glioblastoma to radiation and kinase inhibitors, prolonging survival in mouse models.

Nearly 500 civil servants working at the EPA have signed an open letter to Administrator Zeldin in a Declaration of Dissent.

Mouse study shows human gut bacteria can absorb PFAS, hinting at potential pathways to cut “forever chemicals” in the body.

Researchers have uncovered new patterns of DNA damage associated with specific chemotherapy drugs to guide cancer treatment for less effects.

A global microbiome preservation effort dubbed “Microbial Noah’s Ark” entered a new phase and announced the creation of ...

Researchers have uncovered how the breakdown of glycogen may protect the brain from neurodegeneration and Alzheimer's.

The new facility will combine academic innovation with industrial applications, catalyzing economic growth and training bioengineers.

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and ...